Income before deduction of interest, taxes and amortization: nasuspharma.com (NSRX)

Brandmark of Nasus Pharma (NSRX)

The non-cyclical demand for nasal products ensures the stability of Nasus Pharma Ltd (NSRX) quotes, particularly during the winter period. Israeli innovations in drug delivery guarantee production stability, while management cohesion optimizes operating expenses. EBITDA fluctuations demonstrate the business's actual cash flow, while the 0.00 level reflects the current magnitude of absolute operating profit.

NSRX nasuspharma.com Profit before payment of interest, taxes and amortization (11/23/2025 - 11/14/2026)

Summary analytical data breakdowns for Nasus Pharma (NSRX)

- market price and analyst price targets:
Stock Price Nasus Pharma Ltd.|NSRX - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Nasus Pharma|NSRX - Total Company Value
- book capitalization information:
Accounting Value per Share Nasus Pharma|NSRX - Company Book Value|Capitalization to Book Value Ratio nasuspharma.com|NSRX - Company Total Assets
- debt level and financial liquidity data:
Total Debt to Capital Nasus Pharma Ltd|NSRX - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Nasus Pharma Ltd.|NSRX - Company Total Debt|Debts to Book Capitalization Nasus Pharma|NSRX - Company Long-Term Debt|Short-Term Debt Volume Nasus Pharma|Intermediate Coverage Ratio nasuspharma.com
- earnings and multiples data:
NSRX - Company Net Income|Forward Earnings Nasus Pharma Ltd|NSRX - P/E Multiple|Future Price to Earnings Multiple Nasus Pharma Ltd.|NSRX - PEG Multiple|EV/EBITDA Multiple Nasus Pharma|NSRX - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Nasus Pharma|NSRX - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months nasuspharma.com|NSRX - Earnings growth in current year|Earnings growth forecast for next year Nasus Pharma Ltd
- sales and revenue data:
NSRX - Company Sales|Company Future Revenue Nasus Pharma Ltd.|NSRX - Price-to-Revenue Ratio|Price-to-Projected Revenue Ratio Nasus Pharma
Fundamental company valuation:NSRX (Nasus Pharma Ltd)
Original product of Nasus Pharma Ltd

The uniqueness of Nasus Pharma Ltd (NSRX) intranasal products faces severe pricing pressure from B2B distributors, making the monitoring of operational efficiency critical. An analysis of historical EBITDA_Co data allows for a real-time assessment of actual cash flow before interest and taxes, identifying the dependence of profit on sales volumes and commercialization terms for a long-term business valuation forecast.

Competitors of Nasus Pharma Ltd (NSRX)

Operating profit EBITDA Indivior Corp INDV|COLL - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization CRON (thecronosgroup.com)|Canopy Growth Corporation (CGC) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization High Tide Inc|Profit before payment of interest, taxes and amortization Aurora Cannabis, Inc.|Operating profit before amortization ACHV (Achieve Life Sciences Inc)|Operating profit EBITDA SKYE|Operating profit EBITDA anebulo.com (ANEB)|Profit before payment of interest, taxes and amortization InterCure INCR|Operating income before deduction of amortization Nutriband Inc (NTRB)|IGC: Operating profit before deduction of amortization|MIRA - Operating profit EBITDA|Flora Growth Corp. (FLGC) - Profit before payment of interest, taxes and amortization|IMCC - Operating income before deduction of amortization|Operating profit before deduction of amortization ADIL|ARTL: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Ensysce Biosciences (ENSC)|TTNP: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA GNLN (Greenlane Holdings)|Income before deduction of interest, taxes and amortization INM|Akanda Corp. - Operating profit EBITDA|ENVB - Operating profit EBITDA|brightgreen.us (BGXX) - Profit before payment of interest, taxes and amortization|Hempacco Co Inc. - Income before deduction of interest, taxes and amortization